(Hypertension. 2002;39:474.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
From the Department of Medicine and Clinical Science, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan.
Correspondence to Yusuke Ohya, MD, PhD, Department of Medicine and Clinical Science, Kyushu University, Graduate School of Medical Sciences, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan. E-mail ohya{at}intmed2.med.kyushu-u.ac.jp
Although the presence of intracellular angiotensin II (Ang II) and of Ang II-binding sites has been reported, their roles in cell function have not been fully clarified. The purpose of the present study was to test the hypothesis that intracellular Ang II modifies voltage-operated Ca2+ channels in vascular smooth muscle. Ca2+ channel currents were recorded in guinea pig mesenteric arterial myocytes with the whole-cell patch-clamp method. Intracellular dialysis of Ang II increased the amplitudes of Ca2+ channel current (133±9% of the control with 10 nmol/L Ang II, n=16). Concomitant dialysis of the Ang II type 1 receptor antagonist, CV-11974 (1 µmol/L, n=11), but not the bath application of this drug, suppressed this Ang II action. In contrast, the dialysis of the Ang II type 2 receptor antagonist, PD123319 (1 µmol/L, n=5), failed to affect the Ang II action. Dialysis of either a phospholipase C inhibitor (U-73122, 10 µmol/L, n=5) or protein kinase C inhibitors (calphostin C, 100 nmol/L, n=5; protein kinase C inhibitor peptide-[19-36], 1 µmol/L, n=5) suppressed the Ang II action. Dialysis of KT5720 (100 nmol/L, n=5), an inhibitor of cAMP-dependent protein kinase, did not affect the Ang II action. Intracellular dialysis of angiotensin I (10 nmol/L) enhanced Ca2+ channel currents (13 3±8%, n=6), which were sensitive to intracellular enalaprilat (1 µmol/L, n=5) or CV-11974 (n=5). These results suggest that intracellular Ang II has a stimulating action on voltage-operated Ca2+ channels in vascular smooth muscle, possibly through intracellular binding sites similar to the Ang II type 1 receptor, which are associated with phospholipase C and protein kinase C.
Key Words: calcium channels muscle, smooth, vascular protein kinases receptors, angiotensin II angiotensin-converting enzyme angiotensin
This article has been cited by other articles:
![]() |
K. M. Baker and R. Kumar Intracellular angiotensin II induces cell proliferation independent of AT1 receptor Am J Physiol Cell Physiol, November 1, 2006; 291(5): C995 - C1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Zhuo, X. C. Li, J. L. Garvin, L. G. Navar, and O. A. Carretero Intracellular ANG II induces cytosolic Ca2+ mobilization by stimulating intracellular AT1 receptors in proximal tubule cells Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1382 - F1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Itoh, J. Kajikuri, T. Tada, Y. Suzuki, and Y. Mabuchi Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries J. Physiol., May 1, 2003; 548(3): 893 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Du, W. Ferguson, and T. Wang Role of PKC and calcium in modulation of effects of angiotensin II on sodium transport in proximal tubule Am J Physiol Renal Physiol, April 1, 2003; 284(4): F688 - F692. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Re Implications of intracrine hormone action for physiology and medicine Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H751 - H757. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |